1.8700
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,852
-4,852
-6,939
-5,106
-2,628
Investing Cash Flow
--
--
-11
-5
--
Financing Cash Flow
6,912
6,912
6,141
5,060
2,844
End Cash Position
2,486
2,486
432
1,241
1,292
Interest Paid Supplemental Data
38
38
14
9
--
Capital Expenditure
--
--
-11
-5
--
Issuance of Capital Stock
6,482
6,482
5,992
5,060
2,844
Issuance of Debt
500
500
--
--
--
Repayment of Debt
-500
-500
--
--
--
Free Cash Flow
-4,852
-4,852
-6,950
-5,111
-2,628
12/31/2021 - 10/21/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1541.HK IMMUNEONCO-B
5.050
0.00%
WXXWY WuXi Biologics (Cayman) Inc.
5.17
0.00%
TIL Instil Bio, Inc.
15.46
+1.01%
ANRO Alto Neuroscience, Inc.
2.2600
+0.44%
9926.HK Akeso, Inc.
82.950
-0.90%
LPCN Lipocine Inc.
3.0000
0.00%
IMUX Immunic, Inc.
0.9800
+3.98%
ANVS Annovis Bio, Inc.
1.2200
-3.17%
BSEM BioStem Technologies, Inc.
12.17
-4.40%
RCKT Rocket Pharmaceuticals, Inc.
6.33
+2.93%